Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20995 | 376 | 37.1 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TETRATHIOMOLYBDATE | Author keyword | 11 | 30% | 8% | 30 |
2 | ATN 224 | Author keyword | 4 | 75% | 1% | 3 |
3 | ANGIOTROPIN CURNP RIBOKINE | Author keyword | 3 | 100% | 1% | 3 |
4 | ANTICOPPER THERAPY | Author keyword | 3 | 100% | 1% | 3 |
5 | ENDOTHELIAL CELL STIMULATING ANGIOGENESIS FACTOR | Author keyword | 2 | 67% | 1% | 2 |
6 | TAUBMAN HLTH 1904 | Address | 2 | 67% | 1% | 2 |
7 | TRIENTINE | Author keyword | 2 | 22% | 2% | 8 |
8 | COPPER CHELATION | Author keyword | 2 | 20% | 2% | 7 |
9 | ALZHEIMERS AMYLOID PRECURSOR | Author keyword | 1 | 50% | 1% | 2 |
10 | COPPER RIBONUCLEOPROTEIN | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTICOPPER | 10 | 73% | 2% | 8 |
2 | COPPER SUPPRESSION | 9 | 83% | 1% | 5 |
3 | NEUROLOGICALLY AFFECTED PATIENTS | 9 | 37% | 5% | 19 |
4 | AMMONIUM TETRATHIOMOLYBDATE | 6 | 22% | 7% | 26 |
5 | SUPEROXIDE DISMUTASE 1 SOD1 | 5 | 63% | 1% | 5 |
6 | TETRATHIOMOLYBDATE | 3 | 13% | 6% | 22 |
7 | ZINC THERAPY | 2 | 25% | 2% | 8 |
8 | ZINC RATIO | 1 | 38% | 1% | 3 |
9 | ANTIANGIOGENIC STRATEGY | 1 | 100% | 1% | 2 |
10 | CAPILLARY ENDOTHELIUM INVITRO | 1 | 50% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION | 2009 | 56 | 60 | 28% |
Metals in the causation and treatment of Wilson's disease and Alzheimer's disease, and copper lowering therapy in medicine | 2012 | 11 | 52 | 42% |
A requirement for copper in angiogenesis | 2004 | 37 | 32 | 69% |
Anticopper therapy against cancer and diseases of inflammation and fibrosis | 2005 | 60 | 40 | 48% |
Role of copper in tumour angiogenesis - clinical implications | 2004 | 53 | 49 | 39% |
The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease | 2014 | 0 | 35 | 80% |
Copper deficiency as an anti-cancer strategy | 2004 | 58 | 54 | 33% |
Control of copper status for cancer therapy | 2005 | 35 | 47 | 36% |
Copper lowering therapy with tetrathiomolybdate as an Antiangiogenic strategy in cancer | 2005 | 33 | 58 | 31% |
Role of Copper in Angiogenesis and Its Medicinal Implications | 2009 | 20 | 96 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TAUBMAN HLTH 1904 | 2 | 67% | 0.5% | 2 |
2 | CHAIR SURG PATHOPHISIOL | 1 | 50% | 0.3% | 1 |
3 | COMP CANC | 1 | 50% | 0.3% | 1 |
4 | COMPREHENS CANC GERIAT | 1 | 50% | 0.3% | 1 |
5 | HEMATOL ON AB VIRAL ONCOGENESIS | 1 | 50% | 0.3% | 1 |
6 | MUSCOLOSKELETAL TISSUE BANK | 0 | 33% | 0.3% | 1 |
7 | BASIC VET RADIOL | 0 | 25% | 0.3% | 1 |
8 | CRAMBLETT MED CLIN | 0 | 25% | 0.3% | 1 |
9 | MFG SECT | 0 | 25% | 0.3% | 1 |
10 | DENTRISTRY | 0 | 20% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169773 | BRANCH SHEMYAKIN BIOORGAN CHEM//HEMATOGENEOUS METASTASIS//PANC02 |
2 | 0.0000141702 | CU ZN RATIO//NSECT//RADIOG CITY COMMUNITY HLTH SCI |
3 | 0.0000129920 | CHORIOALLANTOIC MEMBRANE//INTUSSUSCEPTIVE MICROVASCULAR GROWTH//INTUSSUSCEPTIVE ANGIOGENESIS |
4 | 0.0000113880 | TNP 470//METHIONINE AMINOPEPTIDASE//AGM 1470 |
5 | 0.0000098542 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y//TARGET BASED DRUG |
6 | 0.0000094656 | HEART ENDOTHELIAL CELLS//MICROVESSEL ENDOTHELIUM//NON MHC |
7 | 0.0000093243 | CORNEAL NEOVASCULARIZATION//LIPID KERATOPATHY//HEMANGIOGENESIS |
8 | 0.0000092882 | RYBINSK RESERVOIR//OC PESTICIDES//LEUCOGRAM |
9 | 0.0000091051 | WILSONS DISEASE//WILSON DISEASE//LEC RAT |
10 | 0.0000088102 | OMENTAL TRANSPOSITION//OMENTUM TRANSPOSITION//BRIDGING FLAP |